Feedback PLC Director/PDMR Shareholding (5199D)
28 Oktober 2020 - 4:10PM
UK Regulatory
TIDMFDBK
RNS Number : 5199D
Feedback PLC
28 October 2020
Feedback plc
Director/PDMR Shareholding
London , UK, 28 October 2020 - Feedback plc (AIM: FDBK,
"Feedback" or the "Company"), the specialist medical imaging
technology company, has been informed that Rory Shaw, Non-Executive
Chairman of the Company, has today purchased 5,235,446 ordinary
shares in the Company ("Ordinary Shares") at an average price of
0.992 pence per Ordinary Share.
Following this purchase, Rory Shaw has a total beneficial
interest in 9,818,780 Ordinary Shares, equivalent to approximately
0.92 per cent. of the Company's issued share capital.
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325
Johnson 236 or 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS")-based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
N otification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Rory Shaw
-------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------
a) Position/status Non-Executive Chairman
-------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Feedback plc
-------------------------- ------------------------------------------
b) LEI 213800UGOF2GT2U2RV90
-------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description of the Ordinary Shares of 0.25p each in Feedback
financial instrument, plc
type of instrument
Identification code Identification code (ISIN) for Feedback
plc ordinary shares: GB0003340550
-------------------------- ------------------------------------------
b) Nature of the transaction Purchase of shares
-------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
1.0334p 1,156,570
0.9948p 1,005,227
0.9896p 1,010,509
0.95p 1,052,631
0.9896p 1,010,509
-------------------------- ------------------------------------------
d) Aggregated information
- Aggregated volume Aggregated volume: 5,235,446
- Price Volume weighted average price: 0.992p
- Principal amount Principal amount: GBP51,951.98
-------------------------- ------------------------------------------
e) Dates of the transaction 28 October 2020
-------------------------- ------------------------------------------
f) Place of transaction London Stock Exchange
-------------------------- ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHPPGQUUUPUGAR
(END) Dow Jones Newswires
October 28, 2020 11:10 ET (15:10 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024